Carlyle, Pacific Equity Partners agree $930m iNova Pharmaceuticals buyout

Buyout houses Carlyle and Pacific Equity Partners have agreed a $930m cash deal for drug developer iNova Pharmaceuticals from US-based Valeant Pharmaceuticals.